Supreme Court Nominee Draws Concern from Environmentalists

President Trump’s pick, Judge Brett Kavanaugh, has often opposed court involvement in environmental and health regulations.

Written byCatherine Offord
| 2 min read
Register for free to listen to this article
Listen with Speechify
0:00
2:00
Share

President Donald Trump named Brett Kavanaugh as his nominee for the US Supreme Court on Monday night (July 9), following the retirement announcement of Justice Anthony Kennedy last month. A conservative with 12 years of experience in the District of Columbia Circuit Court, Kavanaugh has already attracted scrutiny for past decisions on scientific matters varying from environmental policy to drug regulation, as well as his well-publicized opposition to abortion rights.

“He is pretty consistently anti-environment on every front,” Bill Snape, a law professor at American University and senior counsel at the Center for Biological Diversity, tells BuzzFeed News. “I call him Lord Voldemort,” Snape adds.

Washington, D.C.–based nonprofit Earthjustice, which litigates environmental issues in the U.S., tweeted yesterday that the choice “jeopardizes people’s ability to rely on the courts to protect their health, safety, and the environment.”

Not everyone has been so critical. Richard Lazarus, a law professor at Harvard ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Related Topics

Meet the Author

  • After undergraduate research with spiders at the University of Oxford and graduate research with ants at Princeton University, Catherine left arthropods and academia to become a science journalist. She has worked in various guises at The Scientist since 2016. As Senior Editor, she wrote articles for the online and print publications, and edited the magazine’s Notebook, Careers, and Bio Business sections. She reports on subjects ranging from cellular and molecular biology to research misconduct and science policy. Find more of her work at her website.

    View Full Profile
Share
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter Logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies